We report a case of tropical pulmonary eosinophilia which masqueraded as asthma for four years.
A 37 year old Indian man, resident in England for 11 years, gave a four year history of intermittent cough, wheeze, and breathlessness. At the onset of his illness asthma had been diagnosed and bronchodilators prescribed. He had never smoked. Referral to a chest clinic was prompted by worsening symptoms for four months, accompanied by sweating and weight loss of 6-5 kg. On examination he looked well but he had a persistent dry cough. There was diminished chest expansion, and auscultation revealed generalised expiratory wheeze as well as many late inspiratory bilateral basal and mid zone crackles. Detailed questioning established that his symptoms had originally started one month after a holiday in north west India.
The chest radiograph showed 2-4 mm nodules in the mid and lower zones superimposed on a background of hazy shadowing (fig 1) . Simple spirometry indicated a restrictive ventilatory defect: FEV, was 1-1 litres (37% of predicted), forced vital capacity (FVC) 1-35 1(34% of predicted) and FEV,/FVC ratio 81 %. Total lung capacity (TLC) was reduced at 2-3 1 (41 % of predicted) and gas transfer was impaired (TLCO = 16-7 ml min-' mm Hg-' (5.6 mmol min-' kPa-'); 56% of predicted). The total peripheral white blood count was 11-8 x 109 1, with 66% eosinophils. The filarial fluorescent antibody titre was very high at 1/512. Total serum immunoglobulin E (IgE) was considerably raised at 5700 U/ml (mean normal 122 U/ ml). Stool After these investigations tropical pulmonary eosinophilia was diagnosed and diethylcarbamazine (total dose 11-4 g over 25 days) was added to the patient's preexisting regimen of salbutamol and beclomethasone inhaled from pressurised aerosols. Within a week of starting this treatment his cough and breathlessness had improved and his peak expiratory flow rate (PEFR) rose simultaneously ( fig 2) . Oral aminophylline (225 mg twice daily) was added to his treatment in an attempt to minimise early morning dips in PEFR.
The chest radiograph had cleared by eight weeks. Repeat lung function tests at this time showed appreciable improvement: FEV, was 2-0 1 (67% of predicted), FVC 2-4 1 (60% of predicted), TLC 3-3 1 (59% of predicted), and Thco 23-2 ml min-' mmHg-1(7-8 mmol min-' kPa-'; 78% of predicted). The '°(fig 2) . This is not a recognised feature of chronic tropical pulmonary eosinophilia, where lung fibrosis and restriction are reported. 29 We report this case for three reasons. Firstly, increased ease of international travel makes tropical pulmonary eosinophilia a "tropicar' disease which may be encountered in Britain. Secondly, variable airflow obstruction may persist in chronic tropical pulmonary eosinophilia, making the diagnosis a possibility even in "asthmatics" who left an endemic area several years before. Finally, uncritical acceptance of PEFR measurements may lead to a diagnosis of asthma,10 hindering further consideration of the underlying pathology in this disease. pulmonary eosinophilia.
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